The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads?
Open accessAbstract
Antimicrobial resistance (AR) is recognized as one of the greatest threats to public health and in global concern. Consequently, the increased morbidity and mortality, which are associated with multidrug resistance bacteria, urgently require the discovery of novel and more efficient drugs. Conversely, cancer is a growing complex human disease that demands new drugs with no or fewer side effects. Most of the drugs currently used in the health care systems were of Streptomyces origin or their synthetic forms. Natural product researches from Streptomyces have been genuinely spectacular over the recent years from extreme environments. It is because of technical advances in isolation, fermentation, spectroscopy, and genomic studies which led to the efficient recovering of Streptomyces and their new chemical compounds with distinct activities. Expanding the use of the last line of antibiotics and demand for new drugs will continue to play an essential role for the potent Streptomyces from previously unexplored environmental sources. In this context, deep-sea, desert, cryo, and volcanic environments have proven to be a unique habitat of more extreme, and of their adaptation to extreme living, environments attribute to novel antibiotics. Extreme Streptomyces have been an excellent source of a new class of compounds which include alkaloids, angucycline, macrolide, and peptides. This review covers novel drug leads with antibacterial and cytotoxic activities isolated from deep-sea, desert, cryo, and volcanic environment Streptomyces from 2009 to 2019. The structure and chemical classes of the compounds, their relevant bioactivities, and the sources of organisms are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170
On the rocks: the microbiology of Antarctic Dry Valley soils
Cary, S. C., McDonald, I. R., Barrett, J. E., & Cowan, D. A. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2281 · Cited by 580
Cathepsin B as a cancer target
Gondi, C. S., & Rao, J. S. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.740461 · Cited by 399
Cited by
Streptomyces: The biofactory of secondary metabolites
Alam, K., Mazumder, A., Sikdar, S., Zhao, Y.-M., Hao, J., Song, C., Wang, Y., Sarkar, R., Islam, S., Zhang, Y., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.968053 · Cited by 456
A Co-Culturing Approach Enables Discovery and Biosynthesis of a Bioactive Indole Alkaloid Metabolite
Maglangit, F., Fang, Q., Kyeremeh, K., Sternberg, J. M., Ebel, R., & Deng, H. (2020) · Molecules · doi:10.3390/molecules25020256 · Cited by 47
Metadata
- Authors
- Sivalingam, P., Hong, K., Pote, J., & Prabakar, K.
- Venue
- International Journal of Microbiology
- Publisher
- Wiley
- Published
- 2019-07-01
- Volume
- 2019
- Pages
- 1-20
- ISSN
- 1687-918X (ISSN-L)
- 1687-9198
- OpenAlex
- W2954180508
- Cited by
- 159
- References
- 3
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? https://app.cochat.ai/papers/10.1155/2019/5283948
- The paper
- Sivalingam, P., Hong, K., Pote, J., & Prabakar, K. (2019). Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? International Journal of Microbiology. https://doi.org/10.1155/2019/5283948
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.